Glial cells and adaptive immunity in frontotemporal dementia with tau pathology
The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
Neuroinflammation is involved in the aetiology of many neurodegenerative disorders including Alzheimer’s disease, Parkinson’s disease and motor neuron disease. Whether neuroinflammation also plays an important role in the pathophysiology of frontotemporal dementia is less well known. Frontotemporal dementia is a heterogeneous classification that covers many subtypes, with the main pathology known as frontotemporal lobar degeneration. The disease can be categorized with respect to the identity of the protein that causes the frontotemporal lobar degeneration in the brain. The most common subgroup describes diseases caused by frontotemporal lobar degeneration associated with tau aggregation, also known as primary tauopathies. Evidence suggests that neuroinflammation may play a role in primary tauopathies with genome-wide association studies finding enrichment of genetic variants associated with specific inflammation-related gene loci. These loci are related to both the innate immune system, including brain resident microglia, and the adaptive immune system through possible peripheral T-cell involvement. This review discusses the genetic evidence and relates it to findings in animal models expressing pathogenic tau as well as to post-mortem and PET studies in human disease. Across experimental paradigms, there seems to be a consensus regarding the involvement of innate immunity in primary tauopathies, with increased microglia and astrocyte density and/or activation, as well as increases in pro-inflammatory markers. Whilst it is less clear as to whether inflammation precedes tau aggregation or vice versa; there is strong evidence to support a microglial contribution to the propagation of hyperphosphorylated in tau frontotemporal lobar degeneration associated with tau aggregation. Experimental evidence—albeit limited—also corroborates genetic data pointing to the involvement of cellular adaptive immunity in primary tauopathies. However, it is still unclear whether brain recruitment of peripheral immune cells is an aberrant result of pathological changes or a physiological aspect of the neuroinflammatory response to the tau pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As gliosis begins as early as 2 months in the rTg4510 model (19–21)”
From Pathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation (2023) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Genomic analysis of reactive astrogliosis
Zamanian, J. L., Xu, L., Foo, L. C., Nouri, N., Zhou, L., Giffard, R. G., & Barres, B. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6221-11.2012 · Cited by 2,404
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Microglia emerge as central players in brain disease
Salter, M. W., & Stevens, B. (2017) · Nature Medicine · doi:10.1038/nm.4397 · Cited by 1,767
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591
NLRP3 inflammasome activation drives tau pathology
Ising, C., Venegas, C., Zhang, S., Scheiblich, H., Schmidt, S. V., Vieira-Saecker, A., Schwartz, S., Albasset, S., McManus, R. M., Tejera, D., et al. (2019) · Nature · doi:10.1038/s41586-019-1769-z · Cited by 1,487
Self-citationAstrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304
Normal aging induces A1-like astrocyte reactivity
Clarke, L. E., Liddelow, S. A., Chakraborty, C., Münch, A. E., Heiman, M., & Barres, B. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800165115 · Cited by 1,237
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Initiative, A. D. N., Shi, Y., Yamada, K., Liddelow, S. A., Smith, S. T., Zhao, L., Luo, W., Tsai, R. M., Spina, S., Grinberg, L. T., et al. (2017) · Nature · doi:10.1038/nature24016 · Cited by 1,220
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124
Microglial Phagocytosis of Live Neurons
Brown, G. C., & Neher, J. J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3710 · Cited by 853
The tripartite synapse: roles for gliotransmission in health and disease
Halassa, M. M., Fellin, T., & Haydon, P. G. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.12.005 · Cited by 852
Inflammasome signalling in brain function and neurodegenerative disease
Heneka, M. T., McManus, R. M., & Latz, E. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0055-7 · Cited by 836
Godbout, J. P., Chen, J., Abraham, J., Richwine, A. F., Berg, B. M., Kelley, K. W., & Johnson, R. W. (2005) · The FASEB Journal · doi:10.1096/fj.05-3776fje · Cited by 813
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Kleinberger, G., Yamanishi, Y., Suárez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009093 · Cited by 798
Semantic dementia: a unique clinicopathological syndrome
Hodges, J. R., & Patterson, K. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70266-1 · Cited by 772
Astrocyte function from information processing to cognition and cognitive impairment
Santello, M., Toni, N., & Volterra, A. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0325-8 · Cited by 737
Coupled Proliferation and Apoptosis Maintain the Rapid Turnover of Microglia in the Adult Brain
Askew, K., Li, K., Olmos-Alonso, A., Garcia-Moreno, F., Liang, Y., Richardson, P., Tipton, T., Chapman, M. A., Riecken, K., Beccari, S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.041 · Cited by 726
Ramsden, M., Kotilinek, L., Forster, C., Paulson, J., McGowan, E., SantaCruz, K., Guimaraes, A., Yue, M., Lewis, J., Carlson, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3279-05.2005 · Cited by 702
The release and trans-synaptic transmission of Tau via exosomes
Wang, Y., Balaji, V., Kaniyappan, S., Krüger, L., Irsen, S., Tepper, K., Chandupatla, R., Maetzler, W., Schneider, A., Mandelkow, E., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0143-y · Cited by 674
Physiological release of endogenous tau is stimulated by neuronal activity
Pooler, A. M., Phillips, E. C., Lau, D. H. W., Noble, W., & Hanger, D. P. (2013) · The EMBO Reports · doi:10.1038/embor.2013.15 · Cited by 642
Hopperton, K. E., Mohammad, D., Trépanier, M. O., Giuliano, V, & Bazinet, R. P. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.246 · Cited by 622
The evolution and pathology of frontotemporal dementia
Kertesz, A., McMonagle, P., Blair, M., Davidson, W., & Munoz, D. G. (2005) · Brain · doi:10.1093/brain/awh598 · Cited by 609
Clinicopathological correlates in frontotemporal dementia
Hodges, J. R., Davies, R. R., Xuereb, J. H., Casey, B., Broe, M., Bak, T. H., Kril, J. J., & Halliday, G. M. (2004) · Annals of Neurology · doi:10.1002/ana.20203 · Cited by 580
The epidemiology of frontotemporal dementia
Onyike, C. U., & Diehl-Schmid, J. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.776523 · Cited by 543
Litvinchuk, A., Wan, Y.-W., Swartzlander, D. B., Chen, F., Cole, A., Propson, N. E., Wang, Q., Zhang, B., Liu, Z., & Zheng, H. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.031 · Cited by 523
Leyns, C. E. G., Ulrich, J. D., Finn, M. B., Stewart, F. R., Koscal, L. J., Remolina Serrano, J., Robinson, G. O., Anderson, E., Colonna, M., & Holtzman, D. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710311114 · Cited by 517
Dejanovic, B., Huntley, M. A., De Mazière, A., Meilandt, W. J., Wu, T., Srinivasan, K., Jiang, Z., Gandham, V., Friedman, B. A., Ngu, H., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.014 · Cited by 517
Cribbs, D. H., Berchtold, N. C., Perreau, V., Coleman, P. D., Rogers, J., Tenner, A. J., & Cotman, C. W. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-179 · Cited by 499
Invited review: Neuropathology of tauopathies: principles and practice
Kovacs, G. G. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12208 · Cited by 492
A transcriptomic atlas of aged human microglia
Olah, M., Patrick, E., Villani, A.-C., Xu, J., White, C. C., Ryan, K. J., Piehowski, P., Kapasi, A., Nejad, P., Cimpean, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02926-5 · Cited by 482
Mittelbronn, M., Dietz, K., Schluesener, H. J., & Meyermann, R. (2001) · Acta Neuropathologica · doi:10.1007/s004010000284 · Cited by 482
Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases
Togo, T., Akiyama, H., Iseki, E., Kondo, H., Ikeda, K., Kato, M., Oda, T., Tsuchiya, K., & Kosaka, K. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00496-9 · Cited by 481
Frontotemporal dementia: Clinicopathological correlations
Forman, M. S., Farmer, J., Johnson, J. K., Clark, C. M., Arnold, S. E., Coslett, H. B., Chatterjee, A., Hurtig, H. I., Karlawish, J. H., Rosen, H. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20873 · Cited by 478
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Moehle, M. S., Webber, P. J., Tse, T., Sukar, N., Standaert, D. G., DeSilva, T. M., Cowell, R. M., & West, A. B. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5601-11.2012 · Cited by 463
Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts
Paloneva, J., Kestilä, M., Wu, J., Salminen, A., Böhling, T., Ruotsalainen, V., Hakola, P., Bakker, A. B. H., Phillips, J. H., Pekkarinen, P., et al. (2000) · Nature Genetics · doi:10.1038/77153 · Cited by 460
Cosenza‐Nashat, M., Zhao, M. ‐., Suh, H. ‐., Morgan, J., Natividad, R., Morgello, S., & Lee, S. C. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.01006.x · Cited by 459
Tau association with synaptic vesicles causes presynaptic dysfunction
Zhou, L., McInnes, J., Wierda, K., Holt, M., Herrmann, A. G., Jackson, R. J., Wang, Y.-C., Swerts, J., Beyens, J., Miskiewicz, K., et al. (2017) · Nature Communications · doi:10.1038/ncomms15295 · Cited by 434
Rayaprolu, S., Mullen, B., Baker, M., Lynch, T., Finger, E., Seeley, W. W., Hatanpaa, K. J., Lomen-Hoerth, C., Kertesz, A., Bigio, E. H., et al. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-19 · Cited by 404
Frontotemporal dementia and its subtypes: a genome-wide association study
Ferrari, R., Hernandez, D. G., Nalls, M. A., Rohrer, J. D., Ramasamy, A., Kwok, J. B. J., Dobson-Stone, C., Brooks, W. S., Schofield, P. R., Halliday, G. M., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70065-1 · Cited by 383
Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)
Dickson, D. W., Kouri, N., Murray, M. E., & Josephs, K. A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9589-0 · Cited by 380
Guerreiro, R. J., Lohmann, E., Brás, J. M., Gibbs, J. R., Rohrer, J. D., Gurunlian, N., Dursun, B., Bilgic, B., Hanagasi, H., Gurvit, H., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.579 · Cited by 374
Long-term cerebral consequences of sepsis
Widmann, C. N., & Heneka, M. T. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70017-1 · Cited by 361
Schmid, C. D., Sautkulis, L. N., Danielson, P. E., Cooper, J., Hasel, K. W., Hilbush, B. S., Sutcliffe, J. G., & Carson, M. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01243.x · Cited by 351
Serio, A., Bilican, B., Barmada, S. J., Ando, D. M., Zhao, C., Siller, R., Burr, K., Haghi, G., Story, D., Nishimura, A. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300398110 · Cited by 345
Glial cell influence on the human blood‐brain barrier
Prat, A., Biernacki, K., Wosik, K., & Antel, J. P. (2001) · Glia · doi:10.1002/glia.1104 · Cited by 334
TREM2 function impedes tau seeding in neuritic plaques
Leyns, C. E. G., Gratuze, M., Narasimhan, S., Jain, N., Koscal, L. J., Jiang, H., Manis, M., Colonna, M., Lee, V. M. Y., Ulrich, J. D., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0433-0 · Cited by 332
Streit, W. J., Xue, Q.-S., Tischer, J., & Bechmann, I. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0142-6 · Cited by 317
Clinicopathological correlations in behavioural variant frontotemporal dementia
Perry, D. C., Brown, J. A., Possin, K. L., Datta, S., Trujillo, A., Radke, A., Karydas, A., Kornak, J., Sias, A. C., Rabinovici, G. D., et al. (2017) · Brain · doi:10.1093/brain/awx254 · Cited by 309
Spiller, K. J., Restrepo, C. R., Khan, T., Dominique, M. A., Fang, T. C., Canter, R. G., Roberts, C. J., Miller, K. R., Ransohoff, R. M., Trojanowski, J. Q., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0083-7 · Cited by 301
Biochemistry of Tau in Alzheimer’s disease and related neurological disorders
Sergeant, N., Bretteville, A., Hamdane, M., Caillet-Boudin, M.-L., Grognet, P., Bombois, S., Blum, D., Delacourte, A., Pasquier, F., Vanmechelen, E., et al. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.2.207 · Cited by 300
Self-citationBemiller, S. M., McCray, T. J., Allan, K., Formica, S. V., Xu, G., Wilson, G., Kokiko-Cochran, O. N., Crish, S. D., Lasagna-Reeves, C. A., Ransohoff, R. M., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0216-6 · Cited by 299
The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer’s disease
Hopp, S. C., Lin, Y., Oakley, D., Roe, A. D., DeVos, S. L., Hanlon, D., & Hyman, B. T. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1309-z · Cited by 286
Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer’s Disease Brain
DeVos, S. L., Corjuc, B. T., Oakley, D. H., Nobuhara, C. K., Bannon, R. N., Chase, A., Commins, C., Gonzalez, J. A., Dooley, P. M., Frosch, M. P., et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00267 · Cited by 285
Inflammatory components in human Alzheimer’s disease and after active amyloid-β42 immunization
Zotova, E., Bharambe, V., Cheaveau, M., Morgan, W., Holmes, C., Harris, S., Neal, J. W., Love, S., Nicoll, J. A. R., & Boche, D. (2013) · Brain · doi:10.1093/brain/awt210 · Cited by 272
Self-citationTFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading
Martini-Stoica, H., Cole, A. L., Swartzlander, D. B., Chen, F., Wan, Y.-W., Bajaj, L., Bader, D. A., Lee, V. M. Y., Trojanowski, J. Q., Liu, Z., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20172158 · Cited by 253
Davies, D. S., Ma, J., Jegathees, T., & Goldsbury, C. (2017) · Brain Pathology · doi:10.1111/bpa.12456 · Cited by 251
Luo, W., Liu, W., Hu, X., Hanna, M., Caravaca, A., & Paul, S. M. (2015) · Scientific Reports · doi:10.1038/srep11161 · Cited by 241
CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice
Mancuso, R., Fryatt, G., Cleal, M., Obst, J., Pipi, E., Monzón-Sandoval, J., Ribe, E., Winchester, L., Webber, C., Nevado, A., et al. (2019) · Brain · doi:10.1093/brain/awz241 · Cited by 235
Sayed, F. A., Telpoukhovskaia, M., Kodama, L., Li, Y., Zhou, Y., Le, D., Hauduc, A., Ludwig, C., Gao, F., Clelland, C., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811411115 · Cited by 229
Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease
Liao, F., Yoon, H., & Kim, J. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000383 · Cited by 221
Ishizawa, K., & Dickson, D. W. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.6.647 · Cited by 209
Lill, C. M., Rengmark, A., Pihlstrøm, L., Fogh, I., Shatunov, A., Sleiman, P. M., Wang, L., Liu, T., Lassen, C. F., Meissner, E., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.12.009 · Cited by 205
Transgenic Mouse Model of Tau Pathology in Astrocytes Leading to Nervous System Degeneration
Forman, M. S., Lal, D., Zhang, B., Dabir, D. V., Swanson, E., Lee, V. M.-Y., & Trojanowski, J. Q. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0081-05.2005 · Cited by 198
Intersection of pathological tau and microglia at the synapse
Vogels, T., Murgoci, A.-N., & Hromádka, T. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0754-y · Cited by 197
In vivo detection of microglial activation in frontotemporal dementia
Cagnin, A., Rossor, M., Sampson, E. L., MacKinnon, T., & Banati, R. B. (2004) · Annals of Neurology · doi:10.1002/ana.20332 · Cited by 187
Agosta, F., Vossel, K. A., Miller, B. L., Migliaccio, R., Bonasera, S. J., Filippi, M., Boxer, A. L., Karydas, A., Possin, K. L., & Gorno-Tempini, M. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812697106 · Cited by 178
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Sanchez-Mejias, E., Navarro, V., Jimenez, S., Sanchez-Mico, M., Sanchez-Varo, R., Nuñez-Diaz, C., Trujillo-Estrada, L., Davila, J. C., Vizuete, M., Gutierrez, A., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1630-5 · Cited by 175
Heterozygous TREM2 mutations in frontotemporal dementia
Borroni, B., Ferrari, F., Galimberti, D., Nacmias, B., Barone, C., Bagnoli, S., Fenoglio, C., Piaceri, I., Archetti, S., Bonvicini, C., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.017 · Cited by 173
In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in progressive supranuclear palsy
Gerhard, A., Trender‐Gerhard, I., Turkheimer, F., Quinn, N. P., Bhatia, K. P., & Brooks, D. J. (2006) · Movement Disorders · doi:10.1002/mds.20668 · Cited by 171
Tai, L. M., Ghura, S., Koster, K. P., Liakaite, V., Maienschein‐Cline, M., Kanabar, P., Collins, N., Ben‐Aissa, M., Lei, A. Z., Bahroos, N., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13072 · Cited by 165
Sessa, G., Podini, P., Mariani, M., Meroni, A., Spreafico, R., Sinigaglia, F., Colonna, M., Panina, P., & Meldolesi, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03729.x · Cited by 165
Molecular Mechanisms of Microglial Motility: Changes in Ageing and Alzheimer’s Disease
Franco-Bocanegra, D. K., McAuley, C., Nicoll, J. A. R., & Boche, D. (2019) · Cells · doi:10.3390/cells8060639 · Cited by 147
Self-citationGiraldo, M., Lopera, F., Siniard, A. L., Corneveaux, J. J., Schrauwen, I., Carvajal, J., Muñoz, C., Ramirez-Restrepo, M., Gaiteri, C., Myers, A. J., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.016 · Cited by 147
Jyothi, H. J., Vidyadhara, D. J., Mahadevan, A., Philip, M., Parmar, S. K., Manohari, S. G., Shankar, S. K., Raju, T. R., & Alladi, P. A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.024 · Cited by 139
Maeda, J., Zhang, M.-R., Okauchi, T., Ji, B., Ono, M., Hattori, S., Kumata, K., Iwata, N., Saido, T. C., Trojanowski, J. Q., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3076-10.2011 · Cited by 136
Sjogren, M. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.019422 · Cited by 125
Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum
Bevan-Jones, W. R., Cope, T. E., Jones, P. S., Kaalund, S. S., Passamonti, L., Allinson, K., Green, O., Hong, Y. T., Fryer, T. D., Arnold, R., et al. (2020) · Brain · doi:10.1093/brain/awaa033 · Cited by 124
Mechanisms of Mononuclear Phagocyte Recruitment in Alzheimers Disease
Hickman, S. E., & Khoury, J. E. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791011982 · Cited by 120
Accumulation of Filamentous Tau in the Cerebral Cortex of Human Tau R406W Transgenic Mice
Ikeda, M., Kawarai, T., Kawarabayashi, T., Matsubara, E., Murakami, T., Sasaki, A., Tomidokoro, Y., Ikarashi, Y., Kuribara, H., Ishiguro, K., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62274-2 · Cited by 120
[ 11 C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy
Passamonti, L., Rodríguez, P. V., Hong, Y. T., Allinson, K. S. J., Bevan-Jones, W. R., Williamson, D., Jones, P. S., Arnold, R., Borchert, R. J., Surendranathan, A., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005610 · Cited by 115
Extracellular Monomeric Tau Is Internalized by Astrocytes
Perea, J. R., López, E., Díez-Ballesteros, J. C., Ávila, J., Hernández, F., & Bolós, M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00442 · Cited by 114
Kiialainen, A., Hovanes, K., Paloneva, J., Kopra, O., & Peltonen, L. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.007 · Cited by 114
Jiang, T., Tan, L., Zhu, X.-C., Zhou, J.-S., Cao, L., Tan, M.-S., Wang, H.-F., Chen, Q., Zhang, Y.-D., & Yu, J.-T. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.019 · Cited by 111
Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy
Nash, K. R., Lee, D. C., Hunt, J. B., Morganti, J. M., Selenica, M.-L., Moran, P., Reid, P., Brownlow, M., Guang-Yu Yang, C., Savalia, M., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.011 · Cited by 108
Patterns of microglial cell activation in frontotemporal lobar degeneration
Lant, S. B., Robinson, A. C., Thompson, J. C., Rollinson, S., Pickering‐Brown, S., Snowden, J. S., Davidson, Y. S., Gerhard, A., & Mann, D. M. A. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12092 · Cited by 102
Alterations in the Peripheral Immune System in Dementia
Busse, M., Michler, E., von Hoff, F., Dobrowolny, H., Hartig, R., Frodl, T., & Busse, S. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161304 · Cited by 94
TYROBP genetic variants in early-onset Alzheimer's disease
Pottier, C., Ravenscroft, T. A., Brown, P. H., Finch, N. A., Baker, M., Parsons, M., Asmann, Y. W., Ren, Y., Christopher, E., Levitch, D., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.07.028 · Cited by 94
Cytokine expression and microglial activation in progressive supranuclear palsy
Fernández-Botrán, R., Ahmed, Z., Crespo, F. A., Gatenbee, C., Gonzalez, J., Dickson, D. W., & Litvan, I. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.06.007 · Cited by 93
Partial reduction of microglia does not affect tau pathology in aged mice
Bennett, R. E., Bryant, A., Hu, M., Robbins, A. B., Hopp, S. C., & Hyman, B. T. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1348-5 · Cited by 91
Microglia display modest phagocytic capacity for extracellular tau oligomers
Majerova, P., Zilkova, M., Kazmerova, Z., Kovac, A., Paholikova, K., Kovacech, B., Zilka, N., & Novak, M. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0161-z · Cited by 90
Linnartz, B., Wang, Y., & Neumann, H. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/587463 · Cited by 87
Quantitative neurohistological features of frontotemporal degeneration
Arnold, S. E., Han, L.-Y., Clark, C. M., Grossman, M., & Trojanowski, J. Q. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00173-1 · Cited by 82
Miyoshi, M., Shinotoh, H., Wszolek, Z. K., Strongosky, A. J., Shimada, H., Arakawa, R., Higuchi, M., Ikoma, Y., Yasuno, F., Fukushi, K., et al. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.04.004 · Cited by 75
Audrain, M., Haure-Mirande, J.-V., Wang, M., Kim, S. H., Fanutza, T., Chakrabarty, P., Fraser, P., St George-Hyslop, P. H., Golde, T. E., Blitzer, R. D., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0258-3 · Cited by 68
Woollacott, I. O. C., Nicholas, J. M., Heslegrave, A., Heller, C., Foiani, M. S., Dick, K. M., Russell, L. L., Paterson, R. W., Keshavan, A., Fox, N. C., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0405-8 · Cited by 62
Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease
Faculty, O. B. O. T. M., Boche, D., Gerhard, A., & Rodriguez-Vieitez, E. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04462-w · Cited by 55
Self-citationMicroglial reaction in Pick's disease
Paulus, W., Bancher, C., & Jellinger, K. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90147-d · Cited by 42
In vivo evidence for pre‐symptomatic neuroinflammation in a MAPT mutation carrier
Bevan‐Jones, W. R., Cope, T. E., Jones, P. S., Passamonti, L., Hong, Y. T., Fryer, T., Arnold, R., Coles, J. P., Aigbirhio, F. I., O'Brien, J. T., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.683 · Cited by 36
Research works printed but not linked: 129
- Abu-Rumeileh, 2019, CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia, Alzheimers Res Ther, 12, 2, 10.1186/s13195-019-0562-4 · DOI · Paper page
- Ahmed, 2015, Rescue of impaired late-phase long-term depression in a tau transgenic mouse model, Neurobiol Aging, 36, 730, 10.1016/j.neurobiolaging.2014.09.015 · DOI
- Ajmone-Cat, 2019, Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death, Sci Rep, 9, 4572, 10.1038/s41598-019-41040-4 · DOI · Paper page
- Allen, 2002, Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein, J Neurosci, 22, 9340, 10.1523/JNEUROSCI.22-21-09340.2002 · DOI · Paper page
- Amin, 2017, What do we know about the inflammasome in humans?, Brain Pathol, 27, 192, 10.1111/bpa.12479 · DOI
- Andreasson, 2001, Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice, J Neurosci, 21, 8198, 10.1523/JNEUROSCI.21-20-08198.2001 · DOI · Paper page
- Babcock, 2003, Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS, J Neurosci, 23, 7922, 10.1523/JNEUROSCI.23-21-07922.2003 · DOI · Paper page
- Barker, 2002, Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank, Alzheimer Dis Assoc Disord, 16, 203, 10.1097/00002093-200210000-00001 · DOI · Paper page
- Bellucci, 2004, Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein, Am J Pathol, 165, 1643, 10.1016/S0002-9440(10)63421-9 · DOI · Paper page
- Beyer, 2018, Translocator protein 18kDa (TSPO) expression in patients with clinically diagnosed progressive supranuclear palsy, J Nucl Med, 59, 1700
- Bigio, 1999, Progressive supranuclear palsy with dementia: cortical pathology, J Neuropathol Exp Neurol, 58, 359, 10.1097/00005072-199904000-00006 · DOI · Paper page
- Boccardi, 2004, APOE and modulation of Alzheimer's and frontotemporal dementia, Neurosci Lett, 356, 167, 10.1016/j.neulet.2003.11.042 · DOI · Paper page
- Boche, 2013, Review: activation patterns of microglia and their identification in the human brain, Neuropathol Appl Neurobiol, 39, 3, 10.1111/nan.12011 · DOI · Paper page
- Bonham, 2018, CXCR4 involvement in neurodegenerative diseases, Transl Psychiatry, 8, 73, 10.1038/s41398-017-0049-7 · DOI · Paper page
- Bouwmeester, 2004, A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway, Nat Cell Biol, 6, 97, 10.1038/ncb1086 · DOI · Paper page
- Boxer, 2013, Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development, Alzheimers Dement, 9, 176, 10.1016/j.jalz.2012.03.002 · DOI · Paper page
- Broce, 2018, Immune-related genetic enrichment in frontotemporal dementia: an analysis of genome-wide association studies, PLoS Med, 15, e1002487, 10.1371/journal.pmed.1002487 · DOI · Paper page
- Brodie, 1998, Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion, J Neuroimmunol, 81, 20, 10.1016/S0165-5728(97)00154-9 · DOI
- Burnouf, 2013, NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model, Aging Cell, 12, 11, 10.1111/acel.12018 · DOI · Paper page
- Carvalho, 2019, Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor, Brain, 142, 3636, 10.1093/brain/awz288 · DOI · Paper page
- Chouery, 2008, Mutations in TREM2 lead to pure early-onset dementia without bone cysts, Hum Mutat, 29, E194, 10.1002/humu.20836 · DOI · Paper page
- Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
- Cuyvers, 2014, Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia, Neurobiol Aging, 35, 726.e11, 10.1016/j.neurobiolaging.2013.09.009 · DOI · Paper page
- Dachsel, 2007, Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions, Acta Neuropathol, 113, 601, 10.1007/s00401-006-0178-1 · DOI
- Dale, 2017, Inflammatory pathology and rapidly progressive dementia contribute to the classic PSP phenotype (P4.014), Neurology, 88, P4, 10.1212/WNL.88.16_supplement.P4.014 · doi:10.1212/wnl.88.16_supplement.p4.014
- Darwent, 2017, Mutations in TYROBP are not a common cause of dementia in a Turkish cohort, Neurobiol Aging, 58, 240.e1, 10.1016/j.neurobiolaging.2017.06.019 · DOI
- Das, 2020, Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia, J Neuroinflammation, 17, 10, 10.1186/s12974-019-1694-y · DOI · Paper page
- Dennis, 2016, Human adult neurogenesis across the ages: an immunohistochemical study, Neuropathol Appl Neurobiol, 42, 621, 10.1111/nan.12337 · DOI · Paper page
- Espeseth, 2008, Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4, Neurobiol Aging, 29, 329, 10.1016/j.neurobiolaging.2006.10.030 · DOI
- Fahrenhold, 2018, TREM2 expression in the human brain: a marker of monocyte recruitment?, Brain Pathol, 28, 595, 10.1111/bpa.12564 · DOI · Paper page
- Farrer, 1997, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium, JAMA, 278, 1349, 10.1001/jama.1997.03550160069041 · DOI · Paper page
- Fennema-Notestine, 2011, Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age, J Alzheimers Dis, 26, 49, 10.3233/JAD-2011-0002 · DOI · Paper page
- Ferrari, 2016, Frontotemporal dementia: insights into the biological underpinnings of disease through gene co-expression network analysis, Mol Neurodegener, 11, 21, 10.1186/s13024-016-0085-4 · DOI · Paper page
- Ferrari, 2017, Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases, J Neurol Neurosurg Psychiatry, 88, 152, 10.1136/jnnp-2016-314411 · DOI · Paper page
- Franco-Bocanegra, 2018, Innate immunity in Alzheimer's disease: the relevance of animal models?, J Neural Transm, 125, 827, 10.1007/s00702-017-1729-4 · DOI · Paper page
- Galimberti, 2015, Inflammatory molecules in Frontotemporal Dementia: cerebrospinal fluid signature of progranulin mutation carriers, Brain Behav Immun, 49, 182, 10.1016/j.bbi.2015.05.006 · DOI
- Gendreau, 2013, Tangles, toxicity, and tau secretion in ad - new approaches to a vexing problem, Front Neurol, 4, 160, 10.3389/fneur.2013.00160 · DOI · Paper page
- Geschwind, 1998, The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia, Ann Neurol, 44, 134, 10.1002/ana.410440122 · DOI · Paper page
- Ghetti, 2015, Invited review: frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging, Neuropathol Appl Neurobiol, 41, 24, 10.1111/nan.12213 · DOI · Paper page
- Ginhoux, 2010, Fate mapping analysis reveals that adult microglia derive from primitive macrophages, Science, 330, 841, 10.1126/science.1194637 · DOI · Paper page
- Gorno-Tempini, 2011, Classification of primary progressive aphasia and its variants, Neurology, 76, 1006, 10.1212/WNL.0b013e31821103e6 · DOI · Paper page
- Hall, 2018, Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders, Sci Rep, 8, 13276, 10.1038/s41598-018-31517-z · DOI · Paper page
- Hampton, 2010, Cell-mediated neuroprotection in a mouse model of human tauopathy, J Neurosci, 30, 9973, 10.1523/JNEUROSCI.0834-10.2010 · DOI · Paper page
- Hardy, 2014, Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not, Exp Neurol, 262, 75, 10.1016/j.expneurol.2013.11.006 · DOI
- Harvey, 2003, The prevalence and causes of dementia in people under the age of 65 years, J Neurol Neurosurg Psychiatry, 74, 1206, 10.1136/jnnp.74.9.1206 · DOI · Paper page
- Hauw, 1994, Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy), Neurology, 44, 2015, 10.1212/WNL.44.11.2015 · DOI · Paper page
- Helboe, 2017, Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model, Brain Res, 1665, 22, 10.1016/j.brainres.2017.04.002 · DOI
- Henderson, 2019, Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease, Acta Neuropathol Commun, 7, 183, 10.1186/s40478-019-0836-x · DOI · Paper page
- Henstridge, 2019, Glial contribution to excitatory and inhibitory synapse loss in neurodegeneration, Front Cell Neurosci, 13, 63, 10.3389/fncel.2019.00063 · DOI · Paper page
- Herx, 2001, Interleukin-1β is required for the early evolution of reactive astrogliosis following CNS lesion, J Neuropathol Exp Neurol, 60, 961, 10.1093/jnen/60.10.961 · DOI · Paper page
- Hoffmann, 2013, Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice, Acta Neuropathol Commun, 1, 82, 10.1186/2051-5960-1-82 · DOI · Paper page
- Hogan, 2016, The prevalence and incidence of frontotemporal dementia: a systematic review, Can J Neurol Sci, 43, S96, 10.1017/cjn.2016.25 · DOI · Paper page
- Hollister, 1997, Neuronal expression of class II major histocompatibility complex (HLA-DR) in 2 cases of Pick disease, Arch Neurol, 54, 243, 10.1001/archneur.1997.00550150011008 · DOI
- Huang, 2011, FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration, PLoS Genet, 7, e1002011, 10.1371/journal.pgen.1002011 · DOI · Paper page
- Hudson, 2005, Astrocytes and microglia differentially regulate trafficking of lymphocyte subsets across brain endothelial cells, Brain Res, 1058, 148, 10.1016/j.brainres.2005.07.071 · DOI
- Inbar, 2010, Possible role of tau in mediating pathological effects of apoE4 in vivo prior to and following activation of the amyloid cascade, Neurodegenerative Dis, 7, 16, 10.1159/000283477 · DOI · Paper page
- Jackson, 2017, Altered Synapse Stability in the Early Stages of Tauopathy, Cell Rep, 18, 3063, 10.1016/j.celrep.2017.03.013 · DOI · Paper page
- Jha, 2018, Functional dissection of astrocyte-secreted proteins: Implications in brain health and diseases, Prog Neurobiol, 162, 37, 10.1016/j.pneurobio.2017.12.003 · DOI
- Jiang, 2018, TREM2 ameliorates neuronal tau pathology through suppression of microglial inflammatory response, Inflammation, 41, 811, 10.1007/s10753-018-0735-5 · DOI
- Josephs, 2011, Neuropathological background of phenotypical variability in frontotemporal dementia, Acta Neuropathol, 122, 137, 10.1007/s00401-011-0839-6 · DOI · Paper page
- Josephs, 2006, Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP, Neurology, 66, 41, 10.1212/01.wnl.0000191307.69661.c3 · DOI · Paper page
- Kaneko, 2010, Nasu-Hakola disease: the first case reported by Nasu and review, Neuropathology, 30, 70, 10.1111/j.1440-1789.2010.01127.x · DOI · Paper page
- Karch, 2012, Extracellular Tau levels are influenced by variability in Tau that is associated with tauopathies, J Biol Chem, 287, 42751, 10.1074/jbc.M112.380642 · DOI · Paper page
- Kida, 1992, Immunohistochemical study of a case with progressive supranuclear palsy without ophthalmoplegia, Acta Neuropathol, 83, 328, 10.1007/BF00296797 · DOI
- Kim, 2019, Neuroinflammation in frontotemporal lobar degeneration revealed by 11C-PBR28 PET, Ann Clin Transl Neurol, 6, 1327, 10.1002/acn3.50802 · DOI
- Knopman, 2005, Antemortem diagnosis of frontotemporal lobar degeneration, Ann Neurol, 57, 480, 10.1002/ana.20425 · DOI · Paper page
- Kobayashi, 1999, KP1 expression of ghost Pick bodies, amyloid P-positive astrocytes and selective nigral degeneration in early onset Picks disease, Clin Neuropathol, 18, 240
- Kober, 2016, Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms, eLife, 5, e20391, 10.7554/eLife.20391 · DOI · Paper page
- Komori, 1998, Inducible nitric oxide synthase (iNOS)-like immunoreactivity in argyrophilic, tau-positive astrocytes in progressive supranuclear palsy, Acta Neuropathol, 95, 338, 10.1007/s004010050808 · DOI
- Kosik, 1989, Developmentally regulated expression of specific tau sequences, Neuron, 2, 1389, 10.1016/0896-6273(89)90077-9 · DOI · Paper page
- Krabbe, 2017, Microglial NFkappaB-TNFalpha hyperactivation induces obsessive-compulsive behavior in mouse models of progranulin-deficient frontotemporal dementia, 5029
- Lattante, 2013, TREM2 mutations are rare in a French cohort of patients with frontotemporal dementia, Neurobiol Aging, 34, 2443.e1, 10.1016/j.neurobiolaging.2013.04.030 · DOI
- Laurent, 2017, Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy, Brain, 140, 184, 10.1093/brain/aww270 · DOI · Paper page
- Laurent, 2014, Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology, Neurobiol Aging, 35, 2079, 10.1016/j.neurobiolaging.2014.03.027 · DOI · Paper page
- Lavisse, 2012, Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging, J Neurosci, 32, 10809, 10.1523/JNEUROSCI.1487-12.2012 · DOI · Paper page
- Lemstra, 2007, Microglia activation in sepsis: a case-control study, J Neuroinflammation, 4, 4, 10.1186/1742-2094-4-4 · DOI
- Ling, 2013, TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT, Neurobiol Aging, 34, 2889.e5, 10.1016/j.neurobiolaging.2013.04.011 · DOI · Paper page
- Lively, 2018, Microglia responses to pro-inflammatory stimuli (LPS, IFNγ+TNFα) and reprogramming by resolving cytokines (IL-4, IL-10), Front Cell Neurosci, 12, 215, 10.3389/fncel.2018.00215 · DOI · Paper page
- Lladó, 2008, Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration, J Neurol, 255, 488, 10.1007/s00415-008-0565-8 · DOI
- Lobo-Silva, 2016, Balancing the immune response in the brain: IL-10 and its regulation, J Neuroinflammation, 13, 297, 10.1186/s12974-016-0763-8 · DOI · Paper page
- Mederos, 2018, Astrocyte-neuron networks: a multilane highway of signaling for homeostatic brain function, Front Synaptic Neurosci, 10, 45, 10.3389/fnsyn.2018.00045 · DOI · Paper page
- Merlini, 2018, Extravascular CD3+ T cells in brains of Alzheimer disease patients correlate with tau but not with amyloid pathology: an immunohistochemical study, Neurodegener Dis, 18, 49, 10.1159/000486200 · DOI · Paper page
- Mishra, 2017, Gene-based association studies report genetic links for clinical subtypes of frontotemporal dementia, Brain, 140, 1437, 10.1093/brain/awx066 · DOI · Paper page
- Mishra, 2016, Astrocytes mediate neurovascular signaling to capillary pericytes but not to arterioles, Nat Neurosci, 19, 1619, 10.1038/nn.4428 · DOI · Paper page
- Mori, 2016, Neuroimmunology of the Interleukins 13 and 4, Brain Sci, 6, 18, 10.3390/brainsci6020018 · DOI · Paper page
- Neher, 2019, Priming microglia for innate immune memory in the brain, Trends Immunol, 40, 358, 10.1016/j.it.2019.02.001 · DOI · Paper page
- Nguyen, 2018, G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain, Hum Mol Genet, 27, 120, 10.1093/hmg/ddx389 · DOI · Paper page
- Nilsson, 2014, Age-related incidence and family history in frontotemporal dementia: data from the Swedish Dementia Registry, PLoS One, 9, e94901, 10.1371/journal.pone.0094901 · DOI · Paper page
- Nimmerjahn, 2005, Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo, Science, 308, 1314, 10.1126/science.1110647 · DOI · Paper page
- Penkowa, 1999, Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice, Glia, 25, 343, 10.1002/(SICI)1098-1136(19990215)25:4<343::AID-GLIA4>3.0.CO;2-V · DOI · Paper page
- Persidsky, 1999, Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis, Am J Pathol, 155, 1599, 10.1016/S0002-9440(10)65476-4 · DOI · Paper page
- Prebil, 2011, Dynamic monitoring of cytosolic glucose in single astrocytes, Glia, 59, 903, 10.1002/glia.21161 · DOI · Paper page
- Rabinovici, 2010, Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management, CNS Drugs, 24, 375, 10.2165/11533100-000000000-00000 · DOI · Paper page
- Rakic, 2018, Systemic infection modifies the neuroinflammatory response in late stage Alzheimer's disease, Acta Neuropathol Commun, 6, 88, 10.1186/s40478-018-0592-3 · DOI · Paper page
- Rascovsky, 2011, Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia, Brain, 134, 2456, 10.1093/brain/awr179 · DOI · Paper page
- Rascovsky, 2005, Rate of progression differs in frontotemporal dementia and Alzheimer disease, Neurology, 65, 397, 10.1212/01.wnl.0000171343.43314.6e · DOI · Paper page
- Reu, 2017, The lifespan and turnover of microglia in the human brain, Cell Rep, 20, 779, 10.1016/j.celrep.2017.07.004 · DOI · Paper page
- Romero-Molina, 2018, Distinct microglial responses in two transgenic murine models of TAU pathology, Front Cell Neurosci, 12, 421, 10.3389/fncel.2018.00421 · DOI · Paper page
- Rubino, 2013, Apolipoprotein E polymorphisms in frontotemporal lobar degeneration: a meta-analysis, Alzheimers Dement, 9, 706, 10.1016/j.jalz.2012.10.013 · DOI · Paper page
- Ruiz, 2014, Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia, Neurobiol Aging, 35, 444.e1-4, 10.1016/j.neurobiolaging.2013.08.011 · DOI · Paper page
- Salamanca, 2019, MIC-MAC: An automated pipeline for high-throughput characterization and classification of three-dimensional microglia morphologies in mouse and human postmortem brain samples, Glia, 67, 1496, 10.1002/glia.23623 · DOI · Paper page
- Sanchez-Contreras, 2017, Study of LRRK2 variation in tauopathy: progressive supranuclear palsy and corticobasal degeneration, Mov Disord, 32, 115, 10.1002/mds.26815 · DOI · Paper page
- Santacruz, 2005, Tau suppression in a neurodegenerative mouse model improves memory function, Science, 309, 476, 10.1126/science.1113694 · DOI · Paper page
- Santos, 2014, Reduced frequency of T lymphocytes expressing CTLA-4 in frontotemporal dementia compared to Alzheimer's disease, Progress Neuropsychopharmacol Biol Psychiatry, 48, 1, 10.1016/j.pnpbp.2013.06.019 · DOI
- Sasaki, 2008, Microglial activation in brain lesions with tau deposits: comparison of human tauopathies and tau transgenic mice TgTauP301L, Brain Res, 1214, 159, 10.1016/j.brainres.2008.02.084 · DOI
- Satoh, 2018, Alzheimer's disease pathology in Nasu-Hakola disease brains, Intractable Rare Dis Res, 7, 32, 10.5582/irdr.2017.01088 · DOI · Paper page
- Schindowski, 2006, Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits, Am J Pathol, 169, 599, 10.2353/ajpath.2006.060002 · DOI · Paper page
- Schofield, 2003, Severity of gliosis in Pick’s disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders, Brain, 126, 827, 10.1093/brain/awg085 · DOI · Paper page
- Shi, 2005, Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation, Acta Neuropathol, 110, 501, 10.1007/s00401-005-1079-4 · DOI
- Shi, 2019, Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model, J Exp Med, 216, 2546, 10.1084/jem.20190980 · DOI · Paper page
- Shiarli, 2006, Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease, Neuropathol Appl Neurobiol, 32, 374, 10.1111/j.1365-2990.2006.00736.x · DOI · Paper page
- Sidoryk-Wegrzynowicz, 2017, Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions, Acta Neuropathol Commun, 5, 89, 10.1186/s40478-017-0478-9 · DOI · Paper page
- Sloan, 2013, Glia as primary drivers of neuropathology in TDP-43 proteinopathies, Proc Natl Acad Sci USA, 110, 4439, 10.1073/pnas.1301608110 · DOI
- Snowden, 2011, The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships, Brain, 134, 2478, 10.1093/brain/awr189 · DOI · Paper page
- Sokolowski, 2011, Phagocytic clearance in neurodegeneration, Am J Pathol, 178, 1416, 10.1016/j.ajpath.2010.12.051 · DOI
- Stamatovic, 2008, Brain endothelial cell-cell junctions: how to "open" the blood brain barrier, Curr Neuropharmacol, 6, 179, 10.2174/157015908785777210 · DOI · Paper page
- Stancu, 2019, Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo, Acta Neuropathol, 137, 599, 10.1007/s00401-018-01957-y · DOI · Paper page
- Starhof, 2018, Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes, J Neuroinflammation, 15, 305, 10.1186/s12974-018-1339-6 · DOI · Paper page
- Tacik, 2017, Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy, Neuropathol Appl Neurobiol, 43, 200, 10.1111/nan.12367 · DOI · Paper page
- Taskesen, 2017, Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS, Sci Rep, 7, 8899, 10.1038/s41598-017-09320-z · DOI
- van Olst, 2020, Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model, Neurobiol Aging, 89, 89, 10.1016/j.neurobiolaging.2020.01.003 · DOI · Paper page
- Venneti, 2013, Molecular imaging of microglia/macrophages in the brain, Glia, 61, 10, 10.1002/glia.22357 · DOI · Paper page
- Venneti, 2008, The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders, J Neuropathol Exp Neurol, 67, 1001, 10.1097/NEN.0b013e318188b204 · DOI · Paper page
- Wang, 2015, Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease, Ann Transl Med, 3, 136
- Woollacott, 2020, Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration, J Neuroinflammation, 17, 234, 10.1186/s12974-020-01907-0 · DOI · Paper page
- Wu, 2019, Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy, Cell Rep, 28, 2111, 10.1016/j.celrep.2019.07.060 · DOI · Paper page
- Xiong, 2011, Clinical comparison of progressive aphasia associated with Alzheimer versus FTD-spectrum pathology, J Neurol Neurosurg Psychiatry, 82, 254, 10.1136/jnnp.2010.209916 · DOI · Paper page
- Xu, 2014, Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice, Neuropathol Appl Neurobiol, 40, 833, 10.1111/nan.12160 · DOI · Paper page
- Yamada, 2014, Neuronal activity regulates extracellular tau in vivo, J Exp Med, 211, 387, 10.1084/jem.20131685 · DOI · Paper page
Cited by
Tauopathies: new perspectives and challenges
Zhang, Y., Wu, K.-M., Yang, L., Dong, Q., & Yu, J.-T. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00533-z · Cited by 323
Microglia and Astrocyte Function and Communication: What Do We Know in Humans?
Garland, E. F., Hartnell, I. J., & Boche, D. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.824888 · Cited by 165
“This emphasizes the need for human comparison, and in the last 20 years, the establishment of brain banks has facilitated the access of human tissue to researchers (Gomez-Nicola and Boche, 2015; Hartnell et al., 2021).”
BackgroundInfluentialSelf-citationPathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation
Ochoa, E., Ramirez, P., Gonzalez, E., De Mange, J., Ray, W. J., Bieniek, K. F., & Frost, B. (2023) · Science Advances · doi:10.1126/sciadv.abq5423 · Cited by 73
Differences in peripheral immune system gene expression in frontotemporal degeneration
Sawyer, R. P., Hill, E. J., Yokoyama, J., Medvedovic, M., Ren, Y., Zhang, X., Choubey, D., Shatz, R. S., Miller, B., & Woo, D. (2022) · Medicine · doi:10.1097/md.0000000000028645 · Cited by 9
Metadata
- Authors
- Hartnell, I. J., Blum, D., Nicoll, J. A. R., Dorothee, G., & Boche, D.
- Affiliations
- Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK
- University of Lille, Inserm, CHU-Lille, UMR-S 1172—Lille Neuroscience and Cognition, Lille, France
- Inserm, Sorbonne University, UMRS 938 Saint-Antoine Research Center, Immune System and Neuroinflammation Laboratory, Hôpital Saint-Antoine, Paris, France
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-01-26
- Volume
- 144
- Issue
- 3
- Pages
- 724-745
- ISSN
- 0006-8950
- 1460-2156
- Cited by
- 42
- References
- 100
- Language
- en
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Funders
- Alzheimer’s Research UK (ARUK-PG2018A-012)
- ANR (ANR-18-CE16-0008)
- Network of Centres of Excellence in Neurodegeneration (CoEN 5008)
- Fondation Plan Alzheimer
- Fondation pour la Recherche Médicale
- LECMA/Fondation Vaincre Alzheimer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.